UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.

Fosså, SD; Kaye, SB; Mead, GM; Cullen, M; de Wit, R; Bodrogi, I; van Groeningen, CJ; (1998) Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. J Clin Oncol , 16 (2) 716 - 724.

Full text not available from this repository.

Abstract

To determine the effect of r-metHu granulocyte colony-stimulating factor (G-CSF) on the proportion of patients with metastatic poor-prognosis malignant germ cell tumors who receive full dose-intensity combination chemotherapy.

Type: Article
Title: Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.
Location: UNITED STATES
Language: English
Keywords: Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Cisplatin, Etoposide, Germinoma, Granulocyte Colony-Stimulating Factor, Humans, Male, Middle Aged, Prognosis, Recombinant Proteins
UCL classification: UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > MRC Clinical Trials Unit at UCL
URI: http://discovery.ucl.ac.uk/id/eprint/166738
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item